Compare Companies
| Field | 🇩🇪 Mynaric | 🇺🇸 Rocket LabNASDAQ: RKLB | 🇺🇸 L3Harris TechnologiesNYSE: LHX | 🇺🇸 Northrop GrummanNYSE: NOC |
|---|---|---|---|---|
| Type | private | public | public | public |
| Country | 🇩🇪 Germany | 🇺🇸 United States | 🇺🇸 United States | 🇺🇸 United States |
| Founded | 2009 | 2006 | 2019 | 1994 |
| CEO | Bulent Altan | Peter Beck | Christopher Kubasik | Kathy Warden |
| Mkt Cap / Valuation | — | ~$9.5B | $56B | $78.0B |
| Employees | ~350 (Munich, Los Angeles, Washington D.C.) | ~2,600+ | ~45,000 | ~95,000 |
| Sector | Laser Communications Terminals | Launch & Space Systems | Defense Sensors & Space Systems | Defense & Space Infrastructure |
| Last raise / Last filing | — | 10-K filed | 10-K filed | 10-K filed |
| Top risks | Production scaling history is the company's weakest track record — repeated 2024 delivery misses (€50–70M guidance cut to €14.1M actual) drove the StaRUG restructuring; volume CONDOR Mk3 output remains the open execution risk under Rocket Lab; Customer concentration on a single buyer (U.S. Space Development Agency, via three primes) means any SDA tranche delay, descope, or budget cut directly hits revenue | Neutron development risk: a Q3 2025 stage-1 tank test failure caused schedule slip; any further major setbacks to a Q4 2026 debut could erode investor confidence and require additional capital.; Customer concentration: SDA and U.S. defense represent the majority of backlog; any budget sequestration or program changes in DoD space spending would materially impact near-term revenue visibility. | Integration and margin risk from the 2023 Aerojet Rocketdyne acquisition — Aerojet segment contributed $2.8B FY2025 revenue but integration complexity and potential pension liabilities remain execution risks.; SDA fixed-price satellite contracts expose L3Harris to cost-overrun risk on 18-satellite T3 production; previous tracking-layer primes have faced margin pressure on new architectures. | Space Systems revenue declined 6% in FY2025 due to wind-down of a canceled classified Space Force program and losing the NGI (Next-Generation Interceptor) contract to Lockheed; recovery depends on new wins.; Sole-source SLS SRB position faces existential risk if NASA accelerates the Starship Human Landing System and reduces Artemis mission count post-Artemis III. |
| Next catalyst | Integration of Mynaric into Rocket Lab Space Systems segment — first consolidated quarterly disclosure (Q3 2026) | Neutron first launch — Q4 2026 (2026-Q4) | NTS-3 launch and on-orbit GPS augmentation demonstrations (2025-Q4) | Gateway HALO + PPE combined launch (lunar orbit) (2027-Q4) |
Maximum 4 companies. Pass slugs in the ids query parameter, comma-separated. Try SpaceX vs Blue Origin vs Rocket Lab vs Firefly.